- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00768872
Spinal Cord Stimulation Research Study (ADR-SCS)
October 13, 2016 updated by: MedtronicNeuro
Neuro Ambulatory Data Recorder (ADR) Spinal Cord Stimulation (SCS) Study
The purpose of this study is to characterize a patient's activity levels before and after spinal cord stimulation therapy.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
66
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Napa, California, United States, 94558
- Napa Pain Institute
-
-
Massachusetts
-
Chestnut Hill, Massachusetts, United States, 02467
- Brigham and Women's Hospital
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Medical Advanced Pain Specialists (MAPS)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Candidates for Spinal Cord Stimulation
Description
Inclusion Criteria:
- 18 years of age or older
- Candidate for SCS device trial
- Subject is ambulatory
- Diagnosed with low back pain or low back pain plus leg pain for at least 6 months
- Undergoing treatment for low back pain or low back pain plus leg pain
- Does not have or has not had a previous SCS implant
- Willing and able to complete protocol requirements
- Willing and able to sign the study-specific Informed Consent form
- Male or non-pregnant female
Exclusion Criteria:
- Have plans to enroll in another clinical study during their participation in this study, or are currently enrolled in a clinical study that could interfere in participation in the trial or affect the scientific soundness of this study
- Cancer or any other malignant disease
- Present or past diagnosis of schizophrenia or of delusional, psychotic, or dissociative disorder
- A pain-related surgery in the previous 12 weeks of enrollment, the intent to undergo surgery during the period of the study
- Non-English speaking or an inability to complete questionnaires accurately
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from Baseline in Physical Activity (total centi-Gs per 5.125 seconds)
Time Frame: 4, 12, 24 weeks post implant
|
4, 12, 24 weeks post implant
|
Change from Baseline in Posture Parameters (minutes per 24 hours)
Time Frame: 4, 12, 24 weeks post implant
|
4, 12, 24 weeks post implant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David M Schultz, MD, Medical Advanced Pain Specialists (MAPS)
- Principal Investigator: Robert Jamison, Ph.D, Brigham and Women's Hospital
- Principal Investigator: Eric Grigsby, M.D., Napa Pain Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
October 7, 2008
First Submitted That Met QC Criteria
October 7, 2008
First Posted (Estimate)
October 8, 2008
Study Record Updates
Last Update Posted (Estimate)
October 14, 2016
Last Update Submitted That Met QC Criteria
October 13, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 1644
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Low Back and Leg Pain
-
Biotronik, Inc.Biotronik Australia Pty Ltd.; BIOTRONIK NeuroRecruitingChronic Low-back Pain | Chronic Leg PainAustralia
-
Biotronik, Inc.CompletedChronic Low Back Pain | Chronic Leg PainUnited States
-
Texas Back InstituteMedtronicUnknownChronic Low Back Pain | Pain in Leg, UnspecifiedUnited States
-
Stimwave TechnologiesAmphia ziekenhuis, Oosterhout, The NetherlandsTerminatedChronic Low Back Pain | Pain in Leg, UnspecifiedNetherlands
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
MedtronicNeuroCompleted
-
Justin Parker Neurological InstituteCompletedChronic Refractory Low Back and Leg PainUnited States
-
Iran University of Medical SciencesNot yet recruitingLow Back Pain | Chronic Low-back Pain | Chronic Non-specific Low Back Pain | Cupping Therapy
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil